Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 19;85(12):2374-2389.e11.
doi: 10.1016/j.molcel.2025.05.017. Epub 2025 Jun 9.

Synaptic activity causes minute-scale changes in BAF complex composition and function

Affiliations

Synaptic activity causes minute-scale changes in BAF complex composition and function

Sai Gourisankar et al. Mol Cell. .

Abstract

Genes encoding subunits of the BAF ATP-dependent chromatin remodeling complex are among the most enriched for deleterious de novo mutations in intellectual disabilities and autism spectrum disorder, but the causative molecular pathways are not understood. Synaptic activity in neurons is critical for learning, memory, and proper neural development. While BAF is required for activity-dependent developmental processes, such as dendritic outgrowth, the immediate molecular consequences of neuronal activity on BAF complexes are unknown. Here, we report that neuronal activity induces dramatic remodeling of the subunit composition of BAF complexes within 15 min, concurrent with both phosphorylation and dephosphorylation of its subunits. These biochemical effects are a convergent phenomenon downstream of multiple calcium-activated signaling pathways in mouse neurons and mouse fibroblasts and correspond to changes in BAF-dependent chromatin accessibility. Our studies imply that BAF decodes signals at the membrane by altering the combinatorial composition of its subunits.

Keywords: ATP-dependent chromatin remodeling; BAF (mSWI/SNF) complex; PBAF; activity-regulated transcription; chromatin accessibility; excitatory stimuli; neuron; polybromo-BAF; proteomics; synaptic activity.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests G.R.C. is a founder and shareholder of Foghorn Therapeutics and Shenandoah Therapeutics.

Update of

Substances

LinkOut - more resources